Aditya Chaubey, PhD
MBA ‘22 @ John Molson School of Business | Corporate Strategy | Startup Ecosystem | Venture Capital | Bioengineering - Clemson University
Aditya Chaubey is a highly experienced and passionate professional with over a decade of research and development experience in biomaterials, tissue engineering, nanotechnology platforms, and cancer biology. He is deeply interested in leveraging technological advances to develop solutions
Show more
14.9
Years of Experience
Education
concordia university
Companies
admare bioinnovations, amacathera, john molson entrepreneurship club, mazumdar shaw center for translational research, university of cincinnati biomedical engineering program university of cincinnati, cincinnati childrens hospital medical center
Reach out to Aditya Chaubey, PhD via Email, InMail and SMS drip
by installing Chrome extension
Aditya Chaubey,'s contact details
Experience
2022 - Present
admare bioinnovations
Intern - Scientific and Business Evaluations, Program Development & Partnerships
2021 - 2022
amacathera
Intern
Worked with the Principal Scientist towards developing target product profile (TPP) for assets.
2021 - Present
john molson entrepreneurship club
President
2012 - 2021
mazumdar shaw center for translational research
Chief Scientific Officer & Principal Scientist, Anti-Cancer Technologies Program
As a founding member of MSCTR I helped define the mission/vision of the organization. I was responsible for establishing the company’s R&D roadmap, setting performance goals and making strategic decisions. • Managed the research budget of the organization leading to over 35 research publications and 12 patent filings • Recruited and supervised the core team of scientists and mentored start-ups in the biotech/healthcare space • Partnered with Strand Life Sciences towards developing “Strand LB Portfolio”, a product suite of genetic tests using liquid biopsy aimed towards cancer patients • Interfaced with clinicians in Narayana Health hospitals to understand unmet clinical needs and how we could design our research programs to be more translational in nature (‘bench-to-bedside’ paradigm) • Oversaw efforts to attract extramural research funding from industry and government agencies • Responsible for commercialization of scientific discoveries arising from MSCTR and alliance management for the organization with both academia and industry • Served on the Scientific Advisory Board of GROW Labs – Narayana Nethralaya (one of India’s largest eye hospitals) My research focused on applying materials science and engineering principles to solve biological problems. The two broad themes are tumor engineering and nanomedicine • Tumor Engineering: Developing biomaterial-based 3D tumor models to understand the role of the microenvironment in cancer initiation and progression and using them in translational applications like personalized medicine and drug testing platforms • Nanomedicine: Exploiting the unique properties of nanoparticles to develop novel drug delivery vehicles and diagnostic platforms • Collaborated with start-ups in diverse areas like regenerative medicine, 3D printing, personalized medicine and assay and diagnostics development • Served as a reviewer for scientific journals (Science Advances, Biosensors, PLoS One etc.)
2010 - 2012
university of cincinnati biomedical engineering program university of cincinnati
Postdoctoral Research Fellow
My primary research focused on the biology of bone regeneration. This entailed performing pre-clinical studies that worked at both ends of the spectrum, the clinical level and the fundamental molecular level. The several strands that tied my research together were: • Developing a novel transgenic mouse model to elucidate the etiology of non-union fractures. • Establishing the efficacy of MRL/MpJ mouse as a model for mammalian bone regeneration • Developing biomaterials-based tissue-engineered systems for orthopedic applications Additionally, I collaborated with orthopedic surgeons at University of Cincinnati College of Medicine to better understand how we could bridge the gap between fundamental research and better clinical outcomes. I also served as reviewer in the Interdisciplinary Grant Program of the university to provide research funding to promising early-stage projects, as well as other scientific journals in the field, and mentored graduate students.
2007 - 2010
cincinnati childrens hospital medical center
Research Fellow
My research focused on probing mechanistic causes of acute myeloid leukemia (AML) and developing novel curative therapeutic strategies. • Identifying novel targets of leukemia oncoproteins • Analyzing the role of microRNA in leukemia • Collaborated with Regulus Therapeutics (San Diego, CA) to evaluate the efficacy of their microRNA platform in preclinical studies • Established a unique RNAi-based therapeutic strategy for treating acute myeloid leukemia (AML)
Experience
8 Skills
Excel
Healthcare
program development
Research
Research and Development (R&D)
Research Scientist
strategy
Venture Capital
Education
2021 - 2022
concordia university
Master of Business Administration - MBA
Colleagues at admare bioinnovations
Aditya Chaubey, PhD
Intern - Scientific and Business Evaluations, Program Development & Partnerships
Others named Aditya Chaubey,
Aditya Chaubey, PhD
Intern - Scientific and Business Evaluations, Program Development & Partnerships
at admare bioinnovations
